Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
Fiche publication
Date publication
mars 2024
Journal
Digestive diseases and sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Peyrin-Biroulet L, Bossuyt P, Bettenworth D, Loftus EV, Anjie SI, D'Haens G, Saruta M, Arkkila P, Park H, Choi D, Kim DH, Reinisch W
Lien Pubmed
Résumé
Infliximab and vedolizumab are widely used to treat Crohn's disease (CD) and ulcerative colitis (UC).
Mots clés
Biologic, Crohn’s disease, Monoclonal antibody, Network meta-analysis, Systematic review, Ulcerative colitis
Référence
Dig Dis Sci. 2024 03 18;: